Brief: TG Therapeutics Announces Additional Data Presentations For Briumvi
18/04/2024 12:35
April 18 (Reuters) - TG Therapeutics Inc TGTX.O :
* TG THERAPEUTICS ANNOUNCES ADDITIONAL DATA PRESENTATIONS
FOR
BRIUMVI® (UBLITUXIMAB-XIIY) IN MULTIPLE SCLEROSIS AT THE
AMERICAN ACADEMY OF NEUROLOGY 2024 ANNUAL MEETING
Source text for Eikon: ID:nGNX7txfyV
Further company coverage: TGTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TG Therapeutics
See all newsTG Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Tg Therapeutics Reports Second Quarter 2026 Financial Results And Raises Briumvi® Revenue Guidance
TG Therapeutics Q2 product revenue rises 70% on BRIUMVI sales
U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj
U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj